This funding supports translational and clinical research aimed at advancing precision medicine for pregnant and lactating women, neonates, and children. Funded activities include developing novel tools and models, understanding drug mechanisms including pediatric ontogeny and physiological changes during pregnancy and lactation, and discovering or enhancing therapeutics for safer, more effective medications in these populations.
Eligible applicants include a wide range of U.S. institutions such as public and private higher education institutions, nonprofits, for-profit organizations, government entities, tribal governments, and small businesses. Specific eligibility details are provided in the funding announcement.
